IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Revance Therapeutics Inc 144A

CUSIP: 761330AA7 | 1 institutional holders

Quarters

Q4 2020Q3 2020Q2 2020Q1 2020
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2020

Kornitzer Capital Management Inc3,000,000
0.0% of portfolio›$3.4K
StyleTurnoverLocationFiled
Kornitzer Capital Management Inc
3,000,000$3.4K0.0%CoreLowShawnee Mission, KS2021-01-29